Published online September 18, 2006
PEDIATRICS Vol. 118 No. 4 October 2006, pp. e1019-e1026 (doi:10.1542/peds.2006-0446)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burwell, L. A.
Right arrow Articles by Fridkin, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burwell, L. A.
Right arrow Articles by Fridkin, S. K.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices

Lauren A. Burwell, MDa,b, David Kaufman, MDc, Jennifer Blakely, MPHb, Barbara J. Stoll, MDd and Scott K. Fridkin, MDb

a Office of Workforce and Career Development
b Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
c Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia
d Department of Pediatrics, Emory University, Atlanta, Georgia

BACKGROUND. Bloodstream infections with Candida species have a high mortality rate in very low birth weight infants. Preliminary data suggest that prophylaxis with fluconazole reduces the incidence of colonization and invasive Candida infections in high-risk, very low birth weight neonates. The extent of antifungal prophylaxis use to prevent neonatal candidemia is unknown.

METHODS. We surveyed a 20% random sample of the members of the American Academy of Pediatrics Section on Perinatal Pediatrics. We collected information on prophylactic agents used, indications for use, and rationale for reported practices.

RESULTS. A total of 219 (47%) of 469 members sampled responded; 3 clinicians who did not provide care to very low birth weight infants were excluded. Antifungal prophylaxis use was reported by 73 (34%) respondents. Agents used included intravenous fluconazole (66%), oral nystatin (59%), and intravenous amphotericin B (21%). Decreased birth weight or early gestational age was the most frequent indication to start prophylaxis (57 [78%]). Respondents who did not use antifungal prophylaxis compared with respondents who used fluconazole prophylaxis were significantly more likely to have concerns about (1) the emergence of antifungal resistance, (2) unclear criteria on which to base the decision to start prophylaxis, and (3) the need for clarification of the role of surveillance cultures.

CONCLUSIONS. Although preliminary data suggest that fluconazole is efficacious to prevent candidemia in a subset of neonates, this practice is not used widely by clinicians who care for very low birth weight infants. Additional efficacy studies should address the emergence of antifungal resistance or clarification of criteria to initiate prophylaxis, including the role of surveillance cultures.


Key Words: candidemia • prophylaxis • prevention • sepsis • survey

Abbreviations: VLBW—very low birth weight • ELBW—extremely low birth weight • AAP—American Academy of Pediatrics


Accepted May 23, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
M Brecht, L Clerihew, and W McGuire
Prevention and treatment of invasive fungal infection in very low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2009; 94(1): F65 - F69.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
C. M. Healy
Fungal Prophylaxis in the Neonatal Intensive Care Unit
NeoReviews, December 1, 2008; 9(12): e562 - e570.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
L Clerihew and W McGuire
Antifungal prophylaxis for very low birthweight infants: UK national survey
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2008; 93(3): F238 - F239.
[Abstract] [Full Text] [PDF]